GIANT BioSystems is revolutionizing antimicrobial susceptibility testing (AST) and drug screening with its groundbreaking microfluidic platform, addressing the urgent need for rapid, low-cost, and precise diagnostics. Traditional AST methods delay appropriate antibiotic adjustments, jeopardizing patient outcomes, increasing mortality rates, and contributing to antimicrobial resistance (AMR). GIANT BioSystems’ platform delivers ultrafast and actionable AST results within just 2-4 hours, significantly faster than conventional methods (2-5 days), enabling precise antibiotic interventions that improve patient care.
Company Details
- Employees
- 2
- Founded
- 2023
- Address
- 570 Westwood Plaza,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.giantbiosystems.com/
- Keywords
- Antimicrobial Resistance, Diagnostics, Drug Screening, Antibiotic Stewardship, Healthcare, Sepsis.
- HQ
- Los Angeles, California
Giant Biosystems Inc. Questions
Giant Biosystems Inc.'s website is https://www.giantbiosystems.com/
Giant Biosystems Inc.'s LinkedIn profile is https://www.linkedin.com/company/giant-bio
Giant Biosystems Inc. has
2 employees.
View email and phone details for 2
employees at Giant Biosystems Inc..
Giant Biosystems Inc.'s industry is
Biotechnology Research
Giant Biosystems Inc.'s top competitors are
Hackcfl,
Gabriel,
Nanores Llc,
Vivosphere,
Xcellassay,
Ionicscale Llc,
Resonantia Diagnostics,
Phimpact Investments,
Intelispark,
Mystudies - Strive For Excellence.
Giant Biosystems Inc.'s categories are Biotechnology Research
Giant Biosystems Inc.'s founding year is 2023
